#Ep 5: The Consistent Compounders Show :Stay tuned to catch Saurabh Mukherjea in conversation with Sohini Andani, Fund Manager, SBI Mutual Fund.
you are here: HomeNewsIndia

Coronavirus update: India records 18,855 fresh cases, 163 more fatalities; recovery rate surges to 96.96%

The death toll due to the viral disease has climbed to 1,54,010 in the country with 163 more fatalities, the ministry's data updated at 8 am showed.

January 29, 2021 / 10:44 AM IST

With 18,855 fresh cases, India's COVID-19 tally has gone up to 1,07,20,048, while the number of people who have recuperated from the disease has surged to 1,03,94,352, pushing the national recovery rate to 96.96 percent, the health ministry said on Friday.

The death toll due to the viral disease has climbed to 1,54,010 in the country with 163 more fatalities, the ministry's data updated at 8 am showed.

The number of people who have recuperated from the disease has surged to 1,03,94,352, pushing the national COVID-19 recovery rate to 96.96 percent, while the case fatality rate stands at 1.44per cent.

The number of active COVID-19 cases in the country remained below two lakh for the 10th consecutive day.

There are 1,71,686 active coronavirus cases in the country, which accounts for only 1.60 percent of the total number of cases, the data stated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7 last year, the 30-lakh mark on August 23, the 40-lakh mark on September 5 and the 50-lakh mark on September 16.

It went past 60 lakh on September 28,70 lakh on October 11, 80 lakh on October 29, 90 lakh on November 20 and the one-crore mark on December 19.

According to the Indian Council of Medical Research (ICMR), a total of 19,50,81,079 samples have been tested for the viral disease across the country, including 7,42,306 on Thursday.
PTI
first published: Jan 29, 2021 10:38 am

stay updated

Get Daily News on your Browser
Sections